- Home
- OBK vs BBNX Comparison
OBK vs BBNX Comparison
Compare OBK & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OBK | BBNX |
|---|---|---|
| Founded | 1912 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | OBK | BBNX |
|---|---|---|
| Price | $39.36 | $29.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $43.00 | $28.09 |
| AVG Volume (30 Days) | 138.4K | ★ 735.3K |
| Earning Date | 01-21-2026 | 10-28-2025 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.91 | N/A |
| Revenue | ★ $325,588,000.00 | $88,570,000.00 |
| Revenue This Year | $13.94 | $52.13 |
| Revenue Next Year | $6.04 | $36.16 |
| P/E Ratio | $20.49 | ★ N/A |
| Revenue Growth | N/A | ★ 67.01 |
| 52 Week Low | $28.80 | $8.89 |
| 52 Week High | $41.17 | $32.71 |
Technical Indicators
Market Signals| Indicator | OBK | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 75.67 | 54.95 |
| Support Level | $38.51 | $27.86 |
| Resistance Level | $39.41 | $30.50 |
| Average True Range (ATR) | 0.83 | 1.78 |
| MACD | 0.20 | -0.24 |
| Stochastic Oscillator | 92.17 | 41.82 |
Price Performance
Historical ComparisonAbout OBK Origin Bancorp Inc.
Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.